Valerio Therapeutics Société anonyme (FRA:C4X)

FRA:C4X Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	80	12	25	16	39	52
Market Cap Growth	603.63%	-54.58%	62.58%	-59.41%	-25.93%	60.45%
Enterprise Value	101	21	22	4	25	40
Last Close Price	0.15	0.08	0.15	0.12	0.41	0.66
PE Ratio	-	-	-	-	-	47.76
PS Ratio	43.81	6.44	14.12	10.84	9.48	29.29
PB Ratio	-9.49	-1.40	1.72	0.70	1.17	1.79
P/TBV Ratio	-	-	-	3.71	2.59	4.74
EV/Sales Ratio	55.21	11.58	12.33	2.50	6.06	22.40
Debt / Equity Ratio	-2.70	-2.00	0.74	0.46	0.30	0.22
Debt / EBITDA Ratio	3.87	-	-	-	-	-
Asset Turnover	0.07	0.07	0.05	0.03	0.08	0.04
Quick Ratio	0.35	0.25	1.05	2.78	4.06	3.77
Current Ratio	0.35	0.25	1.17	2.88	4.27	3.83
Return on Equity (ROE)	-	-731.83%	-109.75%	-70.86%	-19.16%	4.71%
Return on Assets (ROA)	-13.78%	-38.74%	-30.39%	-22.25%	-7.01%	-11.61%
Return on Capital (ROIC)	-21.69%	-60.44%	-40.91%	-28.42%	-8.93%	-15.99%
Return on Capital Employed (ROCE)	667.60%	4041.70%	-78.90%	-47.60%	-12.10%	-19.30%
Earnings Yield	-16.44%	-207.23%	-80.02%	-125.10%	-15.41%	2.09%
FCF Yield	-11.99%	-110.66%	-69.13%	-63.51%	-22.61%	-9.22%
Buyback Yield / Dilution	3.99%	-13.81%	-27.86%	-19.88%	-17.03%	-23.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.